| Literature DB >> 35267677 |
Samantha Free-Manjarrez1, Luis Mojica1, Hugo Espinosa-Andrews1, Norma Morales-Hernández1.
Abstract
The work aimed to develop a gel as a protective barrier of common bean protein hydrolysates to be incorporated into a Greek-style yogurt and evaluate the sensory perception and biological potential. The gel was formed by complex coacervation and induced heat at a pH 3.5 and 3:1 biopolymer ratio (whey protein and gum arabic). The gel presented a 39.33% yield, low syneresis (0.37%), and a gel strength of 100 gf. The rheological properties showed an elastic behavior (G' > G″). The gel with the most stable characteristics favored the incorporation of 2.3 g of hydrolysates to be added into the Greek-style yogurt. Nutritionally, the Greek-style yogurt with the encapsulated hydrolysates presented 9.96% protein, 2.27% fat, and 1.76% carbohydrate. Syneresis (4.64%), titratable acidity (1.39%), and viscoelastic behavior presented similar characteristics to the Greek-style control yogurt. The bitterness and astringency in yogurt with encapsulated hydrolysates decreased 44% and 52%, respectively, compared to the yogurt control with the unencapsulated hydrolysates. The Greek-style yogurt with the encapsulated hydrolysates showed the ability to inhibit enzymes related to carbohydrate metabolism (α-amylase (92.47%) and dipeptidyl peptidase-4 (75.24%) after simulated gastrointestinal digestion). The use of gels could be an alternative to transporting, delivering, and masking off-flavors of common bean protein hydrolysates in food matrices to decrease glucose absorption for type 2 diabetes patients.Entities:
Keywords: Greek-style yogurt; common bean protein hydrolysates; complex coacervation; functional food; gel
Year: 2022 PMID: 35267677 PMCID: PMC8912654 DOI: 10.3390/polym14050854
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Interrelation between yield, gel strength, syneresis, and rheology of W-GEL.
| Tx. | Concentration | Ration. | Yield | Gel Strength | Syneresis | Rheology G′(Pa) | |
|---|---|---|---|---|---|---|---|
| (%) | (WPC-GA) | (%) | (gf) | (%) | Ɯ (0.1) | Ɯ (100) | |
| W-GEL 1 | 7.5 | 5:1 | 36.56 ± 1.17 a | 55 ± 2 a | 4.20 ± 0.05 a | 5722 a | 13,490 a |
| W-GEL 2 | 7.5 | 3:1 | 35.78 ± 1.35 a | 96 ± 5 b | 2.71 ± 0.25 b | 3753 b | 9044 b |
| W-GEL3 | 5.0 | 5:1 | 35.33 ± 1.89 a | 159 ± 8 c | 3.89 ± 0.62 a | 5473 a | 13,680 a |
| W-GEL 4 | 5.0 | 3:1 | 39.33 ± 1.76 a | 100 ± 2 b | 0.37 ± 0.25 c | 5508 a | 13,730 a |
Tx: Treatment. W-GEL: WPC:GA gel without BPH. Values are the mean of three replicates ± standard deviation. Lower case letters mean significantly different by column. (p < 0.05).
Figure 1Bromatological composition of control yogurt and BPH-GEL-yogurt. BPH-GEL-yogurt: Greek-style yogurt with BPH encapsulated in a gel; control yogurt: Greek-style yogurt without gel and BPH. Values are the mean of two replicates ± standard deviation. Lowercase letters mean significantly different by parameter. (p < 0.05).
Figure 2Physicochemical analysis of control yogurt and BPH-GEL-yogurt. BPH-GEL-yogurt: Greek-style yogurt with BPH encapsulated in a gel; control yogurt: Greek-style yogurt without gel and BPH. Values are the mean of three replicates ± standard deviation. Lowercase letters mean significantly different by parameter. (p < 0.05).
Figure 3Rheological properties of control yogurt and BPH-GEL-yogurt. The evaluation was made in function of G′ and G″. BPH-GEL-yogurt: Greek-style yogurt with BPH encapsulated in a gel; control yogurt: Greek-style yogurt without gel and BPH.
Figure 4(a) Cross-section confocal microscopy of BPH-Gel, where BPH (yellow) is encapsulated in a gel (Blue). (b) Confocal microscopy of BPH-Gel (blue) encapsulating BPH (yellow). (c) Confocal microscopy of Greek-style yogurt (gray zone) with BPH-Gel, where BPH is encapsulated in a gel (blue).
Figure 5Bitterness and astringency of BPH-GEL-yogurt and BPH-Ue-yogurt. BPH-GEL-yogurt: Greek-style yogurt with BPH encapsulated in a gel; BPH-Ue-yogurt: Greek-style yogurt with unencapsulated BPH. Lowercase letters mean significantly different by the descriptor. (p < 0.05).
Biological potential of common bean protein hydrolysates. Inhibition of α-amylase and DPP-IV of BPH-GEL-yogurt and control yogurt.
| Treatment | Sample | α-Amylase Inhibition | DPP-IV Inhibition |
|---|---|---|---|
| (%) | (%) | ||
| BPH-GEL-yogurt | Initial | 1.55 ± 1.61 aA | ND |
| Stomach | 2.90 ± 0.18 aA | ND | |
| Intestine | 92.47 ± 0.58 bA | 75.24 ± 1.43 A | |
| Control yogurt | Initial | 0.39 ± 4.37 aA | ND |
| Stomach | 0.063 ± 3.5 aA | ND | |
| Intestine | 89.03 ± 0.97 bB | 69.13 ± 0.74 B |
Sample Concentration: 1 mg protein hydrolysate/mL. BPH-GEL-yogurt: Greek-style yogurt with BPH encapsulated in a gel; control yogurt: Greek-style yogurt without gel and BPH. Values are the mean of three replicates ± standard deviation. Lowercase letters (a, b) in the same treatment and capital letters (A, B) by type of samples means significantly different (p < 0.05).